IDEAYA Biosciences
IDYA
28 hedge funds and large institutions have $45M invested in IDEAYA Biosciences in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
1.15% less ownership
Funds ownership: 54.85% → 53.7% (-1.2%)
3% less funds holding
Funds holding: 29 → 28 (-1)
46% less capital invested
Capital invested by funds: $83.6M → $45M (-$38.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$190K |
| 2 |
Millennium Management
New York
|
+$146K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$76.8K |
| 4 |
Goldman Sachs
New York
|
+$46.1K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.07M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$520K |
| 3 |
OGC
One68 Global Capital
New York
|
-$209K |
| 4 |
6CM
683 Capital Management
New York
|
-$168K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$148K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PHK
26
Point72 Hong Kong
Hong Kong
| $1K | – | – | – |
|
|
OGC
27
One68 Global Capital
New York
| – | -$209K | -27,914 | Closed |
|
|
6CM
28
683 Capital Management
New York
| – | -$168K | -22,364 | Closed |
|
|
AIM
29
Alambic Investment Management
Belvedere,
California
| – | -$148K | -19,753 | Closed |
|
|
PCM
30
Prelude Capital Management
New York
| – | -$13K | -1,674 | Closed |
|
|
CSS
31
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$8.89K | -1,255 | -92% |
|
|
TRCT
32
Tower Research Capital (TRC)
New York
| – | -$3K | -436 | Closed |
|
33
Wells Fargo
San Francisco,
California
| – | +$248 | +35 | New |
|
IDYA Hedge Fund Activity: Q1 2020 in Review
28 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2020, worth a combined $45M — down 46% from $83.6M a quarter earlier.
Fund positioning in IDYA was balanced in Q1 2020: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $190K. The largest seller was BVF Inc, cutting an estimated $1.07M.
- 28 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2020, down from 29 in Q4 2019.
- Funds reported $45M of IDEAYA Biosciences stock for Q1 2020, down 46% quarter-over-quarter.
- 5 funds opened new IDEAYA Biosciences positions in Q1 2020 and 5 closed out, a net change of 0 holders.
- The largest IDEAYA Biosciences buyer in Q1 2020 was BlackRock, an estimated $190K added.
- The largest IDEAYA Biosciences seller in Q1 2020 was BVF Inc, an estimated $1.07M sold.
Based on aggregated 13F filings for Q1 2020.